Baxter International Inc. (BAX)
NYSE
Closed
Oct 7, 2026
Day's Range
23.8252 wk Range
15.73Overview - BAX - Baxter International Inc.
Key Statistics
Valuation
Enterprise Value
19.57B
P/E (Trailing)
‪86.30‬
P/E (Forward)
‪11.47‬
PEG Ratio
‪2.58‬
Price / Sales (TTM)
‪1.05‬
Price / Book
‪1.94‬
EV / EBITDA
‪10.38‬
Profitability
Gross Margin
‪34.86%‬
Profit Margin
‪-9.26%‬
Operating Margin
‪14.42%‬
Return on Assets
‪2.84%‬
Return on Equity
‪-14.37%‬
Ownership
Shares Outstanding
516.99M
Float
514.41M
Short % of Shares Outstanding
‪7.09%‬
Held by Insiders
‪0.33%‬
Held by Institutions
‪110.21%‬
Price stats
Beta
‪0.59‬
50-Day Avg
‪25.10‬
200-Day Avg
‪20.71‬
Dividends
Payout Ratio
‪307.69%‬
Frequency
Quarterly
Analyst Consensus
13 analysts
Average price target
‪$ 28.73‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BAX - Baxter International Inc.
Peers - BAX - Baxter International Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on NYSE.
Profile Summary - BAX - Baxter International Inc.
About
Baxter International Inc. is a global healthcare company focused on providing essential medical products and technologies used in hospitals, clinics, surgery centers, pharmacies, and home-care settings. Baxter International Inc. develops and supplies infusion systems, sterile intravenous solutions, injectable…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
